Stock-Based Compensation Expense - Schedule of Stock Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	12 Months Ended
Mar. 31, 2025	Dec. 31, 2024
Number of Shares Subject to Options
Beginning balance (in shares)	27,458
Granted (in shares)	0
Cancelled, forfeited, and expired (in shares)	(12)
Exercised (in shares)	(4,631)
Ending balance (in shares)	22,815	27,458
Exercisable (in shares)	22,729
Vested and expected to vest (in shares)	22,815
Weighted-Average Exercise Price (per Option)
Beginning balance (in dollars per share)	$ 3.08
Granted (in dollars per share)	0
Cancelled (in dollars per share)	5.21
Exercised (in dollars per share)	2.63
Ending balance (in dollars per share)	3.17	$ 3.08
Exercisable (in dollars per share)	3.16
Vested and expected to vest (in dollars per share)	$ 3.17
Weighted-Average Remaining Contractual Term (Years)	3 years 7 months 24 days	4 years 2 months 26 days
Exercisable, weighted-average remaining contractual term	3 years 7 months 20 days
Vested and expected to vest, weighted-average remaining contractual term	3 years 7 months 24 days
Aggregate Intrinsic Value	$ 1,257,523	$ 1,504,261
Exercisable, aggregate intrinsic value	1,252,945
Vested and expected to vest, aggregate intrinsic value	$ 1,257,523

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.